3Zieglschmid V, Hollmann C, Bocher O. Detection of disseminated tumor cells in peripheral blood[J]. Crit Rev Clin Lab Sci, 2005,42:155.
4Mocelln S, Kelhol Z U, Rossic R, et al. Circulating tumor cells: the 'leukemic phase' of solid cancers[J]. Trends Mol Med, 2006,12 (3):130-139.
5Miller A B, Hoogstraten B,Staquet M,et al. Reporting results of cancer treatment[J]. Cancer, 1981,47:207-214.
6Harris L, Fritsche H, Mennel R, et al. American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer[J]. J Clin Oncol,2007,25(33):5287-5312.
7Braun S, Cevatli B, Assemiet C, et al. Comparative analysis of micrometastasis lo the bone marrow and lymph nodes of nodenegative breast cancer patients receiving no adjuvant therapy[J]. J Clin Onc,2001,19(5) :1468-1475.
8Cristofanilli M, Budd G T, Ellis M J, et al. Circulating tumor cells,disease progression and survival in metastatic breast cancer[J]. N Engl J Med,2004,351(8):781-791.
9Kosmas C, Tsavaris N B, Soukouli G, et al. Changes of cerebrospinal fluid tumor marker levels may predict response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer[J]. Med Oncol, 2005,22(2):123- 128.
10Smith B, Slade M, English J, et al. Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immuneyto chemical techniques[J]. J Clin Oncol,2000,18(7):1432-1439.
